Degenerative Disc Disease Market Forecast - 2032; NSAIDs, Opioids, and others are major revenue generators
April 12, 2024 10:28 ET
|
Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Degenerative Disc Disease - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.Key...
Degenerative Disc Disease Drug Pipeline Research Report 2024 Featuring Spine BioPharma, Angitia Biopharmaceuticals, Mesoblast, BioRestorative Therapies, and DiscGenics, Inc.
April 11, 2024 09:08 ET
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Degenerative Disc Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Degenerative Disc...
DelveInsight Highlights Major Advances, Transformative Therapies, and 15+ Leading Players Wheeling the Degenerative Disc Disease Pipeline Landscape
February 20, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 20, 2023 (GLOBE NEWSWIRE) -- DelveInsight Highlights Major Advances, Transformative Therapies, and 15+ Leading Players Wheeling the Degenerative Disc Disease Pipeline Landscape ...